Skip to main content
Premium Trial:

Request an Annual Quote

MetaMorphix Expands Agreement with Sequenom for New Animal Tests

NEW YORK (GenomeWeb News) - Sequenom said today that MetaMorphix will expand its use of Sequenom’s MassARRAY and iPlex technologies for its genotyping and selection services.
The agreement extends an earlier partnership that the companies signed in 2005.
The new agreement will allow MMI to handle increased sample orders coming from its DNA-based livestock and companion animal diagnostic products, Sequenom said.
Last year MMI released seed-stock and feedlot management products through a partnership with the agricultural company Cargill. MMI also offers the Canine Heritage Breed test, which customers use to determine the breed composition of mixed breed dogs.
Sequenom’s CEO, Harry Stylii, said the MassARRAY is a “a synergistic fit for MMI's genotyping endeavors as it is highly suitable for cost effective testing of a large number of DNA samples."
Financial terms of the agreement were not released.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.